As previously stated, low levels of SEPP1 are associated with a heightened risk of cardiovascular issues, cerebral atrophy, hormonal abnormalities, and sensory deficits [22,25]; human compliance, using exercise as a tool to curb these risks, could have profound effects. This evidence concerns the gene SELENOP and Cerebral atrophy.